In the Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium Glucose Cotransporter-2 Inhibitors (CVD-REAL) study, which investigated CV outcomes in patients with T2D in real-world clinical practice, patients who had initiated therapy with SGLT-2is (n = 166,033) were compared with those who received another form of glucose-lowering therapy (n = 226,221) [Citation35]
Without treatment, pellagra can be fatal, which is an important factor to be considered, since its low prevalence in developed countries causes missed diagnosis and delayed treatments (12, 54)
If youre looking for a less costly alternative to a medication like semaglutide, you can explore other GLP-1 agonist options
Free radical mediated cell toxicity by redox cycling chemicals
A decade ago, if someone told me we'd be discussing 30% weight loss from a subcutaneous injection, I would have called it fantasy
Report Adverse Events: Patients can submit adverse event reports to the FDA through the MedWatch program